We are live on ! Find out more
VC

Voss Capital Portfolio holdings

AUM $1.88B
1-Year Est. Return 1.03%
This Fund
S&P 500
This Quarter Est. Return
+3.7%
1 Year Est. Return
-1.03%
3 Year Est. Return
+41.79%
5 Year Est. Return
+147.21%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$148M
Cap. Flow
+$104M
Cap. Flow %
7.18%
Top 10 Hldgs %
62.18%
Holding
67
New
11
Increased
28
Reduced
12
Closed
13

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$57.4M
2
FLYW icon
Flywire
FLYW
+$52.6M
3
CROX icon
Crocs
CROX
+$41M
4
SN icon
SharkNinja
SN
+$35.1M
5
POWL icon
Powell Industries
POWL
+$33.5M

Top Sells

Rank Stock Value
1
RTO icon
Rentokil
RTO
+$43.6M
2
CRH icon
CRH
CRH
+$32.3M
3
UNF icon
Unifirst Corp
UNF
+$28.5M
4
CNH
CNH Industrial
CNH
+$18.6M
5
AMTM
Amentum Holdings
AMTM
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 35.31%
2 Consumer Discretionary 27.97%
3 Industrials 21.13%
4 Communication Services 6.2%
5 Materials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MHO icon
26
M/I Homes
MHO
$3.74B
$14M 0.97%
125,000
+82,625
+195% +$8.97M
LGIH icon
27
LGI Homes
LGIH
$1.27B
$11.6M 0.8%
+225,000
New +$12.3M
SHC icon
28
Sotera Health
SHC
$5.09B
$8.34M 0.57%
750,000
+250,000
+50% +$2.93M
ARKO icon
29
ARKO Corp
ARKO
$896M
$6.46M 0.45%
1,527,413
-889,599
-37% -$3.89M
AVTR icon
30
Avantor
AVTR
$9.32B
$6.06M 0.42%
+450,000
New +$6.16M
ALX
31
Alexander's
ALX
$1.3B
$5.7M 0.39%
25,290
+8,080
+47% +$1.74M
ECVT icon
32
Ecovyst
ECVT
$1.32B
$5.28M 0.36%
641,317
-557,664
-47% -$3.91M
RGNX icon
33
Regenxbio
RGNX
$620M
$4.72M 0.33%
575,000
+185,000
+47% +$1.55M
EXTR icon
34
Extreme Networks
EXTR
$3.94B
$4.49M 0.31%
250,000
-938,770
-79% -$13.8M
BLDR icon
35
Builders FirstSource
BLDR
$7.15B
$4.08M 0.28%
35,000
+26,151
+296% +$3.02M
DHI icon
36
D.R. Horton
DHI
$40B
$3.87M 0.27%
30,000
+5,000
+20% +$616K
BXC icon
37
BlueLinx
BXC
$422M
$3.59M 0.25%
48,210
+35,710
+286% +$2.5M
BLD
38
DELISTED
TopBuild
BLD
$3.24M 0.22%
+10,000
New +$2.97M
SXT icon
39
Sensient Technologies
SXT
$5.26B
$2.46M 0.17%
+25,000
New +$2.24M
AMRZ
40
Amrize Ltd
AMRZ
$27.1B
$2.2M 0.15%
+44,305
New +$2.24M
RNTX
41
Rein Therapeutics
RNTX
$63.1M
$2.01M 0.14%
1,433,686
+442,970
+45% +$798K
CGEM icon
42
Cullinan Oncology
CGEM
$1.01B
$1.9M 0.13%
251,717
+76,717
+44% +$616K
KURA icon
43
Kura Oncology
KURA
$800M
$1.76M 0.12%
305,659
+55,659
+22% +$341K
ACTU
44
Actuate Therapeutics
ACTU
$26.6M
$1.75M 0.12%
286,140
+143,759
+101% +$1.26M
QURE icon
45
uniQure
QURE
$3.03B
$1.74M 0.12%
+125,000
New +$1.68M
XERS icon
46
Xeris Biopharma Holdings
XERS
$1.39B
$1.49M 0.1%
319,800
+44,800
+16% +$205K
RCKT icon
47
Rocket Pharmaceuticals
RCKT
$340M
$1.23M 0.08%
500,000
+67,760
+16% +$343K
IOVA icon
48
Iovance Biotherapeutics
IOVA
$1.82B
$1.16M 0.08%
+672,570
New +$1.67M
RMNI icon
49
Rimini Street
RMNI
$449M
$943K 0.06%
+250,000
New +$835K
NATH icon
50
Nathan's Famous
NATH
$402M
$641K 0.04%
5,800
-4,200
-42% -$428K
1
2
3

Similar funds

TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
OPCM
Osborne Partners Capital Management San Francisco, California $1.89B AUM 16.21% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return

Voss Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Voss Capital held 67 positions worth $1.45B, up 11% from $1.3B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Voss Capital deployed $104M of net new capital in Q2 2025, opening 11 new positions and adding to 28 existing holdings. Its largest new stake was Crocs: 402,500 shares worth $40.8M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Rentokil, an estimated $43.6M trimmed.

  • Voss Capital's largest Q2 2025 buy was Crocs: 402,500 shares worth $40.8M.
  • Voss Capital added most to FIVE9 in Q2 2025, an estimated $57.4M increase.
  • Voss Capital's biggest Q2 2025 reduction was Rentokil, cutting an estimated $43.6M.
  • Voss Capital fully exited Unifirst Corp in Q2 2025, selling an estimated $28.5M.
  • Voss Capital's ten largest holdings make up 62% of its $1.45B portfolio in Q2 2025.
  • Voss Capital opened 11 new positions and closed 13 in Q2 2025.
  • Voss Capital's portfolio value rose 11% quarter-over-quarter to $1.45B.

Based on Voss Capital's 13F filing for Q2 2025, filed 13 Aug 2025.